Kaya Holdings (KAYS) Gross Margin (2014 - 2025)

Kaya Holdings (KAYS) recorded quarterly Gross Margin of 99.3% in Q3 2025, up 198.22% quarter-over-quarter from 33.3% in Q2 2025, and up 836.0% on a YoY basis from 10.61% in Q3 2024.

Kaya Holdings (KAYS) Gross Margin (2014 - 2025) Analysis & Trends

Kaya Holdings' Gross Margin history runs 12 years deep, the most recent figure standing at 99.3% for Q3 2025.

  • In Q3 2025, Gross Margin rose 836.0% year-over-year to 99.3%; the TTM figure through Sep 2025 stood at 522.23% (up 47863.0% YoY), while the FY2024 annual figure was 5.13%, down 6369.0% from the prior year.
  • Gross Margin was 99.3% for Q3 2025 at Kaya Holdings, up from 33.3% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 99.3% in Q3 2025 to a low of 29.52% in Q1 2025.
  • Historically, Gross Margin has averaged 63.76% across 5 years, with a median of 65.86% in 2023.
  • The sharpest annual moves came in 2023 and 2024: Gross Margin sank 3439 bps in 2023, then soared 4176 bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 72.68% in 2021, then dropped by 8 bps to 66.76% in 2022, then sank by 52 bps to 32.37% in 2023, then jumped by 129 bps to 74.12% in 2024, then surged by 34 bps to 99.3% in 2025.
  • The last three Gross Margin figures came in at 99.3% (Q3 2025), 33.3% (Q2 2025), and 29.52% (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 49.52%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 71.66%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.26%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -293.83%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 61.20%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 65.25%
10 Kaya Holdings - - 5,370.00 99.30%

Historic Data

Download Data
DateValue
Sep 30, 2025 99.30%
Jun 30, 2025 33.30%
Mar 31, 2025 29.52%
Dec 31, 2024 74.12%
Sep 30, 2024 90.93%
Mar 31, 2024 52.14%
Dec 31, 2023 32.37%
Sep 30, 2023 62.57%
Jun 30, 2023 64.23%
Mar 31, 2023 65.60%
Dec 31, 2022 66.76%
Sep 30, 2022 65.44%
Jun 30, 2022 69.93%
Mar 31, 2022 66.13%
Dec 31, 2021 72.68%
Sep 30, 2021 70.92%
Jun 30, 2021 63.74%
Mar 31, 2021 68.01%
Dec 31, 2020 62.40%
Sep 30, 2020 61.50%